Drugs@FDA: FDA-Approved Drugs
Company: GALT PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DORAL | QUAZEPAM | 15MG | TABLET;ORAL | Prescription | None | Yes | Yes |
DORAL | QUAZEPAM | 7.5MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/27/1985 | ORIG-1 | Approval | Type 1 - New Molecular Entity | STANDARD |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/018708Orig1s000rev.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
01/13/2023 | SUPPL-29 | Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/018708Orig1s029ltr.pdf | |
02/05/2021 | SUPPL-27 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018708s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/018708Orig1s027ltr.pdf | |
02/06/2019 | SUPPL-25 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018708s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/018708Orig1s025ltr.pdf | |
12/16/2016 | SUPPL-23 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018708s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/018708Orig1s023ltr.pdf | |
04/19/2013 | SUPPL-21 | Manufacturing (CMC) |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018708s020s021lbl.pdf | |
04/19/2013 | SUPPL-20 | Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018708s020s021lbl.pdf | |
04/13/2010 | SUPPL-18 | Labeling |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018708s018lbl.pdf | |
10/30/2007 | SUPPL-17 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/018708s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/018708s017ltr.pdf | |
11/14/2002 | SUPPL-14 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/18708slr014ltr.pdf |
09/12/1996 | SUPPL-13 | Manufacturing (CMC)-Packaging |
Label is not available on this site. |
||
02/03/1994 | SUPPL-12 | Manufacturing (CMC)-Packaging |
Label is not available on this site. |
||
11/12/1993 | SUPPL-10 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
07/11/1991 | SUPPL-9 | Manufacturing (CMC)-Packaging |
Label is not available on this site. |
||
02/08/1991 | SUPPL-7 | Manufacturing (CMC)-Expiration Date |
Label is not available on this site. |
||
08/05/1991 | SUPPL-6 | Manufacturing (CMC)-Packaging |
Label is not available on this site. |
||
02/08/1991 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/26/1987 | SUPPL-3 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
02/26/1987 | SUPPL-2 | Manufacturing (CMC)-Expiration Date |
Label is not available on this site. |
||
02/26/1987 | SUPPL-1 | Labeling |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
01/13/2023 | SUPPL-29 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf | |
01/13/2023 | SUPPL-29 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf | |
02/05/2021 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018708s027lbl.pdf | |
02/06/2019 | SUPPL-25 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018708s025lbl.pdf | |
12/16/2016 | SUPPL-23 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018708s023lbl.pdf | |
04/19/2013 | SUPPL-21 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018708s020s021lbl.pdf |
04/19/2013 | SUPPL-20 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018708s020s021lbl.pdf | |
04/19/2013 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018708s020s021lbl.pdf | |
04/13/2010 | SUPPL-18 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018708s018lbl.pdf | |
10/30/2007 | SUPPL-17 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/018708s017lbl.pdf |